Clinical prudence urged in testing for steatotic liver disease

We read with interest “[Approach to steatotic liver disease in the office. Diagnosis, management, and proposed nomenclature][1]” by Szilagyi and Hilzenrat in the April 2025 issue of Canadian Family Physician .[1][2] The increasing burden of metabolic risk factors is an important issue in primary